Wedbush Initiates Coverage On Cubist Pharmaceuticals
November 04, 2014 at 11:09 AM EST
Wedbush initiated coverage on Cubist Pharmaceuticals Inc (NASDAQ: CBST) with a Neutral rating and $70 price target. Analysts led ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.